FDA clears Entellus Med's ENT dilation device for persistent ETD [Seeking Alpha]
ENTELLUS MEDICAL (ENTL)
Last entellus medical earnings: 11/1 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.entellusmedical.com
Company Research
Source: Seeking Alpha
The FDA grants 510(k) clearance for the use of Entellus Medical's (NASDAQ: ENTL ) XprESS ENT Dilation System in patients with persistent Eustachian tube dysfunction (ETD). Colorado Sinus Institute's Jeffery Cutler, M.D., says, “Eustachian tube dilation is an excellent additional option for my patients with Eustachian tube dysfunction. Myringotomy with tube placement has been the standard for recalcitrant ear pressure and fullness for some time. Unfortunately, some patients experience worsening of hearing when tubes are placed this way. Transnasal Eustachian tube dilation has prevented this side effect and has been very well tolerated. The XprESS device is an excellent additional option for the treatment for ETD, and we look forward to our patients realizing the benefit in our practice.” Now read: Aerie Pharma's Rhopressa maintains safety profile over six months while matching timolol »
Show less
Read more
Impact Snapshot
Event Time:
ENTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENTL alerts
High impacting ENTELLUS MEDICAL news events
Weekly update
A roundup of the hottest topics